Trials / Completed
CompletedNCT01707446
Role of Cerebral Oximetry In Reducing Delirium After Complex Cardiac Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Delirium after cardiac surgery is reported in a range of 3-47% of patients. Delirium is a serious complication that results in prolonged length of stay, increased health care costs and is associated with higher death rates. The exact cause involved in the development of delirium after cardiac surgery is unclear. The latest advancement in near-infrared spectroscopy (NIRS) Oximetry offers real-time management of patients at risk of brain injury. This approved device will monitor cerebral oxygenation during and 24hr after cardiac surgery, recording oxygenation in real time allowing the clinical team the opportunity to intervene early to prevent ischemia and possibly preventing untoward events. Adverse events followed include, but are not limited to, stroke, (transient ischemic attacks), heart attack, (myocardial infarction), clots found in lungs (pulmonary embolism), kidney failure, pneumonia, cause of death for 30-days after surgery (all cause mortality). Hypothesis: Perioperative restoration of rSO2 desaturation to baseline values results in lower delirium rates after complex cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter) | In the intervention group, an alarm threshold at 75% of the baseline rSO2 value will be established. Based on predetermined algorithm the rSO2 will be maintained at or above 75% of the baseline measurements. |
| OTHER | An alarm threshold at 75% of the baseline rSO2 value | If the threshold of \< 75% from baseline is reached for \> 1 minute an algorithm geared to restore rSO2 to baseline levels will be implemented. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-12-01
- Completion
- 2016-08-01
- First posted
- 2012-10-16
- Last updated
- 2017-06-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01707446. Inclusion in this directory is not an endorsement.